What Researchers Did
Researchers conducted a review of published studies focusing on the assessment of tumour hypoxia, patient selection, and strategies to overcome hypoxia during cancer treatment.
What They Found
The review found that tumour hypoxia is a characteristic feature in many solid tumours, decreasing the therapeutic efficacy of radiation treatment, surgery, and some forms of chemotherapy. New assessment methods have established its prognostic significance, and several genes and proteins were identified as potential candidates for future predictive assays.
What This Means for Canadian Patients
This research emphasizes the importance of accurately assessing tumour hypoxia to better select Canadian patients for hypoxia-modifying treatments. Improved patient selection can help optimize treatment strategies and enhance the quality of life for individuals undergoing cancer therapy.
Canadian Relevance
There is no direct Canadian connection mentioned in this study.
Study Limitations
The clinical usefulness of identified markers and combinations for predicting treatment outcomes still requires validation in prospective trials.